Home » Topics » BioWorld Science

BioWorld Science
RSS

FXa-DOAC reversal with no thrombogenic potential seen with VMX-C001

July 28, 2021

Ghent University Hybrid CAR-T cell platform has dual anti-HIV effects

July 28, 2021

Discovery novel GPR119 agonist with excellent blood glucose-lowering effects

July 28, 2021

FDA clears IND for lanraplenib in patients with AML

July 28, 2021

Clinical trial of AP-003 in COVID-19 approved in Chile

July 28, 2021

T-cell exhaustion is durable, but specific

July 28, 2021

Evaluation of a mucosal vaccine based on recombinant N. lactamica expressing heterologous antigens

July 28, 2021

Bristol Myers Squibb patents diacylglycerol kinase alpha/zeta inhibitors

July 28, 2021

Dual GCGR and GLP-1 agonists patented by Merck & Co.

July 28, 2021

Medshine Discovery discovers ketohexokinase inhibitors

July 28, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...